NHSClass II

Assay, Genotype, Hiv Drug Resistance, In Vitro

21 CFR 866.3950 / Immunology

NHS is the FDA product code for Assay, Genotype, Hiv Drug Resistance, In Vitro, a class II device type, regulated under 21 CFR 866.3950. FDA's definition for this code reads: "Hiv-1 drug resistance genotyping". As of 2026-09-10, FDA records hold no 510(k) clearances under this code and no recalls.

Classification record

Product code: NHS
Device name: Assay, Genotype, Hiv Drug Resistance, In Vitro
FDA definition: Hiv-1 drug resistance genotyping
Regulation: 21 CFR 866.3950
Device class: Class II
Review panel: Immunology
Submission type: 510(k)
Implant: No
Life sustaining or supporting: No
GMP exempt: No
Third party review eligible: No
Ingested clearances: 0
Ingested recalls: 0

Companies listing this code with FDA

Companies whose registered establishments list this code

No registered establishment in MDM’s records lists product code NHS.

Recent clearances

Product code NHS

FDA records hold no clearances under product code NHS.

Recent recalls

Product code NHS

FDA records show no recalls under product code NHS.

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device classification database, ingested from openFDA. The definition, regulation number, device class and review panel are FDA’s own fields, reproduced without editing.

MDM adds the counts: clearances by decision year, the applicants holding the most clearances under this code, recalls that name it, and the registered establishments that list it. Every count is computed from ingested records only.

Data as of 2026-10-05, the FDA export date for this dataset. Page last changed 2026-09-05. View this product code on fda.gov (opens on fda.gov)